Your browser doesn't support javascript.
loading
Characterization of Immune Checkpoint Inhibitor-Induced Myasthenia Gravis Using the US Food and Drug Administration Adverse Event Reporting System.
Niimura, Takahiro; Zamami, Yoshito; Miyata, Koji; Mikami, Takahisa; Asada, Mizuho; Fukushima, Keijo; Yoshino, Masaki; Mitsuboshi, Satoru; Okada, Naoto; Hamano, Hirofumi; Sakurada, Takumi; Matsuoka-Ando, Rie; Aizawa, Fuka; Yagi, Kenta; Goda, Mitsuhiro; Chuma, Masayuki; Koyama, Toshihiro; Izawa-Ishizawa, Yuki; Yanagawa, Hiroaki; Fujino, Hiromichi; Yamanishi, Yoshihiro; Ishizawa, Keisuke.
Affiliation
  • Niimura T; Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
  • Zamami Y; Clinical Research Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan.
  • Miyata K; Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
  • Mikami T; Department of Pharmacy, Okayama University Hospital, Okayama, Japan.
  • Asada M; Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
  • Fukushima K; Department of Neurology, Tufts Medical Center, Boston, Massachusetts, USA.
  • Yoshino M; Department of Pharmacy, Tokyo Medical and Dental University Hospital, Tokyo Medical and Dental University, Tokyo, Japan.
  • Mitsuboshi S; Department of Medical Molecular Informatics, Meiji Pharmaceutical University, Tokyo, Japan.
  • Okada N; Department of Pharmacology for Life Sciences, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
  • Hamano H; Department of Pharmacy, Niigata Prefectural Cancer Center Hospital, Niigata, Japan.
  • Sakurada T; Department of Pharmacy, Kaetsu Hospital, Niigata, Japan.
  • Matsuoka-Ando R; Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
  • Aizawa F; Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan.
  • Yagi K; Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
  • Goda M; Clinical Research Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan.
  • Chuma M; Department of Pharmacy, Okayama University Hospital, Okayama, Japan.
  • Koyama T; Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan.
  • Izawa-Ishizawa Y; Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
  • Yanagawa H; Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan.
  • Fujino H; Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
  • Yamanishi Y; Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan.
  • Ishizawa K; Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
J Clin Pharmacol ; 63(4): 473-479, 2023 04.
Article in En | MEDLINE | ID: mdl-36453166

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myasthenia Gravis / Myocarditis / Myositis Type of study: Screening_studies Limits: Aged / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: J Clin Pharmacol Year: 2023 Document type: Article Affiliation country: Japón Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myasthenia Gravis / Myocarditis / Myositis Type of study: Screening_studies Limits: Aged / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: J Clin Pharmacol Year: 2023 Document type: Article Affiliation country: Japón Country of publication: Reino Unido